These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6987785)

  • 1. Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy.
    Lipinski M; Tursz T; Kreis H; Finale Y; Amiel JL
    Transplantation; 1980 Mar; 29(3):214-8. PubMed ID: 6987785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural cell-mediated cytotoxicity of kidney allograft recipients].
    Hirabayashi S; Ono Y; Ohshima S
    Hinyokika Kiyo; 1987 Apr; 33(4):501-7. PubMed ID: 3303871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    J Clin Immunol; 1984 Jul; 4(4):312-8. PubMed ID: 6378956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon alpha on natural killer cell cytotoxicity in kidney transplant recipients.
    Kelly AP; Schooley RT; Rubin RH; Hirsch MS
    Clin Immunol Immunopathol; 1984 Jul; 32(1):20-8. PubMed ID: 6329567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    Transplant Proc; 1984 Dec; 16(6):1475-7. PubMed ID: 6390849
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.
    Dokhelar MC; Wiels J; Lipinski M; Tetaud C; Devergie A; Gluckman E; Tursz T
    Transplantation; 1981 Jan; 31(1):61-5. PubMed ID: 7015602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in natural killer cell activity in kidney allograft recipients.
    Moreau JF; Soulillou JP; Ythier A; Hegaret A; Fauconnier B
    Ann Immunol (Paris); 1983; 134C(2):191-205. PubMed ID: 6191619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological monitoring and early prediction of rejection in renal allograft recipients.
    Attallah AM; Abdelghaffar H; Alghraoui F; Fawzy A; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
    Int Arch Allergy Appl Immunol; 1987; 84(1):10-7. PubMed ID: 3305373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs.
    Thomas JM; Carver M; Cunningham P; Sash C; Park K; Thomas F
    Transplantation; 1989 Feb; 47(2):209-15. PubMed ID: 2645699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of antibody-dependent cellular cytotoxicity and lectin-induced cellular cytotoxicity tests for renal graft rejection.
    Wasik M; Gradowska L; Rowińska D; Lao M; Orłowski T
    Transplantation; 1981 Sep; 32(3):217-21. PubMed ID: 7025371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents.
    Shin BH; Ge S; Mirocha J; Karasyov A; Vo A; Jordan SC; Toyoda M
    Transplantation; 2014 Feb; 97(3):294-300. PubMed ID: 24342979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell activity and antibody-dependent cellular cytotoxicity in patients under various immunosuppressive regimens.
    Müller C; Schernthaner G; Kovarik J; Kalinowska W; Zielinski CC
    Clin Immunol Immunopathol; 1987 Jul; 44(1):12-9. PubMed ID: 3297437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
    Dupont E
    Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.
    Lipinski M; Virelizier JL; Tursz T; Griscelli C
    Eur J Immunol; 1980 Apr; 10(4):246-9. PubMed ID: 6156843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.